文献速递放疗物理与技术姑息放疗与转移瘤

COVID-19对拉丁美洲放射治疗服务影响的调查

COVID's Impact on Radiation Oncology: A Latin American Survey Study.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2020-01-01

该研究于2020年5月6日至30日在拉丁美洲15个国家发放美国放射肿瘤学会COVID-19调查问卷,229家机构中115家(50%)完整回复。仅2.6%中心关闭,患者量中位下降8%,53%机构收入减少≥20%,51.3%缺乏个人防护装备。

要点

  • 仅2.6%的拉丁美洲放疗中心在疫情期间关闭。
  • 患者量中位下降8%,53%机构估计收入减少≥20%。
  • 51.3%中心报告个人防护装备短缺,27%报告人员短缺。

核心结论

  • 拉丁美洲放疗服务在COVID-19疫情期间患者量中位下降8%,多数中心维持运行但面临防护装备和人员短缺。

主要发现

  • 仅2.6%的中心在疫情期间关闭。
  • 每中心放射肿瘤科医生中位4名(范围1-27),放射治疗师中位9名(范围1-100)。
  • 2019年治疗新患者中位600例(范围24-6200),患者量中位下降8%(范围1%-90%),中位53例(范围1-490)仍在治疗中。
  • 53%的机构估计收入减少20%或更多。
  • 51.3%的中心报告个人防护装备短缺,27%报告因COVID-19导致人员短缺。

关键数值与推荐

  • 低风险实体报告治疗延迟:早期乳腺癌42.6%、低风险前列腺癌67%、非恶性疾病42.6%。
  • 22.6%的中心报告在指定治疗时间治疗COVID-19患者,10.4%报告使用专用 bunker。
  • 64.3%的机构已启动远程医疗,其中29.6%用于治疗中患者、34.8%用于治疗后患者。

临床怎么用

  • 区域调查数据可用于制定适合拉丁美洲放疗服务的干预策略,以减轻疫情对人员和患者的影响。

局限性

  • 仅50%(115/229)的机构完整回复,可能存在无应答偏倚。
  • 调查时间为2020年5月6日至30日,仅反映该时段横断面信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The impact of the COVID-19 pandemic on Latin American radiation therapy services has not yet been widely assessed. In comparison to centers in Europe or the United States, the scarcity of data on these terms might impair design of adequate measures to ameliorate the pandemic's potential damage. The first survey-based analysis revealing regional information is herein presented. METHODS AND MATERIALS: From May 6 to May 30, 2020, the American Society for Radiation Oncology's COVID-19 Survey was distributed across Latin America with support of the local national radiation therapy societies. Twenty-six items, including facility demographic and financial characteristics, personnel and patient features, current and expected impact of the pandemic, and research perspectives, were included in the questionnaire. RESULTS: Complete responses were obtained from 115 (50%) of 229 practices across 15 countries. Only 2.6% of centers closed during the pandemic. A median of 4 radiation oncologists (1-27) and 9 (1-100) radiation therapists were reported per center. The median number of new patients treated in 2019 was 600 (24-6200). A median 8% (1%-90%) decrease in patient volume was reported, with a median of 53 patients (1-490) remaining under treatment. Estimated revenue reduction was 20% or more in 53% of cases. Shortage of personal protective equipment was reported in 51.3% of centers, and 27% reported personnel shortage due to COVID-19. Reported delays in treatment for low-risk entities included early stage breast cancer (42.6%), low-risk status prostate cancer (67%), and nonmalignant conditions (42.6%). Treatment of COVID-19 patients at designated treatment times and differentiated bunkers were reported in 22.6% and 10.4% of centers, respectively. Telehealth initiatives have been started in 64.3% of facilities to date for on-treatment (29.6%) and posttreatment (34.8%) patients. CONCLUSIONS: Regional information regarding COVID-19 pandemic in Latin America may help elucidate suitable intervention strategies for personnel and patients. Follow-up surveys will be performed to provide dynamic monitoring the pandemic's impact on radiation therapy services and adoption of ameliorating measures.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Martinez D, Sarria GJ, Wakefield D, et al. COVID's Impact on Radiation Oncology: A Latin American Survey Study. Int J Radiat Oncol Biol Phys. 2020. PMID: 32890516. doi:10.1016/j.ijrobp.2020.06.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。